David B. Hellmann

6.9k total citations
92 papers, 4.1k citations indexed

About

David B. Hellmann is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, David B. Hellmann has authored 92 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 27 papers in Rheumatology and 12 papers in Surgery. Recurrent topics in David B. Hellmann's work include Vasculitis and related conditions (35 papers), Systemic Lupus Erythematosus Research (15 papers) and Otitis Media and Relapsing Polychondritis (11 papers). David B. Hellmann is often cited by papers focused on Vasculitis and related conditions (35 papers), Systemic Lupus Erythematosus Research (15 papers) and Otitis Media and Relapsing Polychondritis (11 papers). David B. Hellmann collaborates with scholars based in United States, United Kingdom and France. David B. Hellmann's co-authors include Michelle Petri, Quinn E. Whiting-O'Keefe, John H. Stone, Julius Birnbaum, Fredrick M. Wigley, Marc C. Hochberg, Stuart M. Levine, James D. Michelson, Mark E. Easley and Roy C. Ziegelstein and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

David B. Hellmann

90 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David B. Hellmann United States 31 1.6k 1.5k 552 491 452 92 4.1k
Aman Sharma India 36 971 0.6× 1.3k 0.9× 1.2k 2.2× 351 0.7× 617 1.4× 383 4.9k
Koert M. Dolman Netherlands 32 764 0.5× 525 0.4× 423 0.8× 254 0.5× 1.0k 2.3× 96 3.2k
Ali H. Hajeer Saudi Arabia 47 1.2k 0.8× 2.0k 1.4× 524 0.9× 548 1.1× 2.5k 5.5× 220 7.6k
Frank T. Saulsbury United States 29 1.3k 0.8× 781 0.5× 477 0.9× 359 0.7× 2.7k 6.0× 96 5.5k
Margret S. Magid United States 33 571 0.3× 897 0.6× 1.4k 2.5× 178 0.4× 439 1.0× 85 3.7k
Luis R. Espinoza United States 45 928 0.6× 3.8k 2.5× 1.2k 2.2× 470 1.0× 1.9k 4.3× 269 7.2k
Betty U. McNeely United States 26 2.2k 1.3× 979 0.7× 2.3k 4.2× 711 1.4× 453 1.0× 1.1k 8.1k
Barbara A. Burke United States 31 1.1k 0.7× 434 0.3× 1.3k 2.3× 204 0.4× 482 1.1× 101 4.5k
Arthur Weinstein United States 43 431 0.3× 2.5k 1.7× 430 0.8× 183 0.4× 1.9k 4.1× 109 5.9k
A J Pinching United Kingdom 30 558 0.3× 379 0.3× 272 0.5× 333 0.7× 613 1.4× 59 3.0k

Countries citing papers authored by David B. Hellmann

Since Specialization
Citations

This map shows the geographic impact of David B. Hellmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Hellmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Hellmann more than expected).

Fields of papers citing papers by David B. Hellmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Hellmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Hellmann. The network helps show where David B. Hellmann may publish in the future.

Co-authorship network of co-authors of David B. Hellmann

This figure shows the co-authorship network connecting the top 25 collaborators of David B. Hellmann. A scholar is included among the top collaborators of David B. Hellmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David B. Hellmann. David B. Hellmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sunness, Janet S., et al.. (2023). HYDROXYCHLOROQUINE CAN BE RESUMED WITH CLOSE MONITORING AFTER RETINOPATHY HAS DEVELOPED, WITHOUT MAJOR VISUAL LOSS: CASE REPORT. Retinal Cases & Brief Reports. 19(2). 253–258.
2.
Golden, Sherita Hill, Eric B Bass, Stephen A. Berry, et al.. (2018). Building Leadership Capacity for Mission Execution in a Large Academic Department of Medicine. The American Journal of Medicine. 132(4). 535–543.
3.
Golden, Sherita Hill, Thomas Cudjoe, Panagis Galiatsatos, et al.. (2018). A Perspective on the Baltimore Freddie Gray Riots: Turning Tragedy Into Civic Engagement and Culture Change in an Academic Department of Medicine. Academic Medicine. 93(12). 1808–1813. 3 indexed citations
4.
Pilla, Scott J., et al.. (2016). Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes. Current Diabetes Reports. 16(10). 91–91. 4 indexed citations
5.
Imboden, John B., David B. Hellmann, & John H. Stone. (2012). Current Rheumatology Diagnosis & Treatment. McGraw-Hill eBooks. 22 indexed citations
6.
Levine, Stuart M., et al.. (2011). Falling through the cracks of vasculitis classification--a report of three patients. Clinical Kidney Journal. 4(5). 327–330. 5 indexed citations
7.
Ratanawongsa, Neda, Cynthia S. Rand, Colleen Christmas, et al.. (2009). Teaching residents to know their patients as individuals. The Aliki Initiative at Johns Hopkins Bayview Medical Center.. PubMed. 72(3). 4–11. 12 indexed citations
8.
Wright, Scott M., David B. Hellmann, & Roy C. Ziegelstein. (2005). 52 precepts that medical trainees and physicians should consider regularly. The American Journal of Medicine. 118(4). 435–438. 1 indexed citations
9.
Hellmann, David B., John H. Stone, Mollie W. Jenckes, et al.. (2003). Domains of health‐related quality of life important to patients with giant cell arteritis. Arthritis Care & Research. 49(6). 819–825. 33 indexed citations
10.
Hellmann, David B.. (2002). Temporal Arteritis. JAMA. 287(22). 2996–2996. 59 indexed citations
11.
Levine, Stuart M., David B. Hellmann, & John H. Stone. (2002). Gastrointestinal involvement in polyarteritis nodosa (1986–2000):. The American Journal of Medicine. 112(5). 386–391. 84 indexed citations
12.
Stone, John H., Gary S. Hoffman, Peter A. Merkel, et al.. (2001). A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score. Arthritis & Rheumatism. 44(4). 912–920. 352 indexed citations
13.
Scatarige, John C., Bruce A. Urban, David B. Hellmann, & Elliot K. Fishman. (2001). Three-Dimensional Volume-Rendering CT Angiography in Vasculitis: Spectrum of Disease and Clinical Utility. Journal of Computer Assisted Tomography. 25(4). 598–603. 12 indexed citations
14.
Stone, John H., et al.. (2001). Etanercept combined with conventional treatment in Wegener's granulomatosis: A six-month open-label trial to evaluate safety. Arthritis & Rheumatism. 44(5). 1149–1154. 179 indexed citations
15.
Whiting-O'Keefe, Quinn E., John H. Stone, & David B. Hellmann. (1999). Validity of a vasculitis activity index for systemic necrotizing vasculitis. Arthritis & Rheumatism. 42(11). 2365–2371. 44 indexed citations
16.
Stebbing, Justin, et al.. (1999). Secondary amyloidosis associated with giant cell arteritis/polymyalgia rheumatica.. PubMed. 26(12). 2698–700. 4 indexed citations
17.
Hwang, Jeong‐Min, Christopher A. Girkin, Julian D. Perry, et al.. (1999). Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment. American Journal of Ophthalmology. 127(1). 102–104. 22 indexed citations
18.
Thomas, Patricia A., Maura McGuire, & David B. Hellmann. (1996). A blueprint for building an AMC-HMO teaching affiliation. Academic Medicine. 71(6). 577–9. 4 indexed citations
19.
Vidt, Donald G., John A. Flynn, & David B. Hellmann. (1995). Methotrexate in rheumatoid arthritis: when NSAIDs fail. Cleveland Clinic Journal of Medicine. 62(6). 351–359. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aman Sharma Breakdown of academic impact, for papers by Koert M. Dolman Breakdown of academic impact, for papers by Ali H. Hajeer Breakdown of academic impact, for papers by Frank T. Saulsbury Breakdown of academic impact, for papers by Margret S. Magid Breakdown of academic impact, for papers by Luis R. Espinoza Breakdown of academic impact, for papers by Betty U. McNeely Breakdown of academic impact, for papers by Barbara A. Burke Breakdown of academic impact, for papers by Arthur Weinstein Breakdown of academic impact, for papers by A J Pinching
Rankless by CCL
2026